Suraksha Diagnostic Ltd — earnings calls

Suraksha Diagnostic reported Q1 FY'27 total income of Rs 887 million, up 21% year-on-year, with EBITDA growing 28% to Rs 315 million and PAT growing 40% to Rs 128 million. The company added one hub and three spoke centres during the quarter, taking its network to 72 centres, and management said centres under two years old turned EBITDA-positive for the first time at 6.5% margin. Management also discussed continued growth in the Suraksha Genomics vertical, which posted revenue of Rs 13.7 million, up 136% year-on-year.

Suraksha Diagnostic reported FY26 revenue from operations of INR3104.1 million, up 23.1% year-on-year, with blended EBITDA margin of 31.73% and PAT of INR314 million. Management said the year included expansion into 68 centers with new hub and spoke launches, alongside investments in genomics, molecular diagnostics and MRI technology. For FY27, management outlined plans to add hubs and spokes in West Bengal and expand into Bihar, Tripura and Jharkhand, while flagging near-term margin pressure from new center ramp-up costs.